Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I-f inhibitor ivabradine in pat

Fox, K., Ferrari, R., Tendera, M., Steg, P., Ford, I. and BEAUTIFUL Steering Committee, (2006) Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I-f inhibitor ivabradine in pat. American Heart Journal, 152, pp. 860-866. (doi: 10.1016/j.ahj.2006.01.013)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ford, Professor Ian
Authors: Fox, K., Ferrari, R., Tendera, M., Steg, P., Ford, I., and BEAUTIFUL Steering Committee,
College/School:College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > Robertson Centre
?? 20206000 ??
Journal Name:American Heart Journal

University Staff: Request a correction | Enlighten Editors: Update this record